{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:31Z","timestamp":1777936171480,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.5980-25","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:26Z","timestamp":1759356506000},"page":"1258-1261","source":"Crossref","is-referenced-by-count":0,"title":["Salvage Surgery for Lesions Resistant to Immune Checkpoint Inhibitors in a Case Suggestive of Pulmonary Pleomorphic Carcinoma"],"prefix":"10.2169","volume":"65","author":[{"given":"Yoshio","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroka","family":"Serizawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kuze","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Gohma","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Yasuhara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sakai City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baldovini C, Rossi G, Ciarrocchi A. Approaches to tumor classification in pulmonary sarcomatoid carcinoma. Lung Cancer (Auckl) 10: 131-149, 2019.","DOI":"10.2147\/LCTT.S186779"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 27: 311-324, 2003.","DOI":"10.1097\/00000478-200303000-00004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hong JY, Choi MK, Uhm JE, et al. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. Med Oncol 26: 287-291, 2009.","DOI":"10.1007\/s12032-008-9117-4"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Bae HM, Min HS, Lee SH, et al. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 58: 112-115, 2007.","DOI":"10.1016\/j.lungcan.2007.05.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hayashi K, Tokui K, Inomata M, et al. Case series of pleomorphic carcinoma of the lung treated with immune checkpoint inhibitors. In Vivo 35: 1687-1692, 2021.","DOI":"10.21873\/invivo.12428"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Matsumoto Y, Miura T, Horiuchi H, Usui K. The successful treatment of pulmonary pleomorphic carcinoma with pembrolizumab: a case report. Case Rep Oncol 10: 752-757, 2017.","DOI":"10.1159\/000479552"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Senoo S, Ninomiya T, Makimoto G, et al. Rapid and long-term response of pulmonary pleomorphic carcinoma to nivolumab. Intern Med 58: 985-989, 2019.","DOI":"10.2169\/internalmedicine.0890-18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Babacan NA, Pina IB, Signorelli D, Prelaj A, Garassino MC, Tanvetyanon T. Relationship between programmed death receptor-ligand 1 expression and response to checkpoint inhibitor immunotherapy in pulmonary sarcomatoid carcinoma: a pooled analysis. Clin Lung Cancer 21: e456-e463, 2020.","DOI":"10.1016\/j.cllc.2020.02.022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schiavon M, Cannone G, Bertolaccini L, et al.; The Lung Oncology Group. Safety and efficacy of salvage surgery after treatment with immune-checkpoint adjuvant inhibitors for advanced non-small cell lung cancer: a multicentric study. J Surg Oncol 131: 371-379, 2025.","DOI":"10.1002\/jso.27920"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamaji M, Ozasa H, Sakamori Y, et al. Characteristics and outcomes of salvage surgery after immune checkpoint inhibitor therapy for initially unresectable non-small cell lung cancer. J Thorac Dis 16: 6094-6100, 2024.","DOI":"10.21037\/jtd-24-891"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ikushima H, Asaga R, Sakatani T, Masuda Y, Morikawa T, Usui K. Successful control of intestinal bleeding from metastasis of pulmonary pleomorphic carcinoma with pembrolizumab: a case report. Medicine (Baltimore) 101: e31220, 2022.","DOI":"10.1097\/MD.0000000000031220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nagase W, Kudo Y, Matsubayashi J, et al. Immunotherapy-extended survival in patients with recurrent pulmonary pleomorphic carcinoma following surgery. Eur J Surg Oncol 51: 109565, 2025.","DOI":"10.1016\/j.ejso.2024.109565"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ma Y, Li W, Li Z, et al. Immunophenotyping of pulmonary sarcomatoid carcinoma. Front Immunol 13: 976739, 2022.","DOI":"10.3389\/fimmu.2022.976739"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Roma L, Ercan C, Conticelli F, et al. Tracing tumor heterogeneity of pleomorphic carcinoma of the lung. J Thorac Oncol 19: 1284-1296, 2024.","DOI":"10.1016\/j.jtho.2024.04.019"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gu SS, Wang X, Hu X, et al. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade. Genome Biol 21: 263, 2020.","DOI":"10.1186\/s13059-020-02166-1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5980-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:49Z","timestamp":1777692109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5980-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5980-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"5980-25"}}